Despite of differences in replication strategy among virus families, some basic principles have remained similar. Analogous mechanisms govern virus entry into cells and the use of enzymes which direct the replication of the virus genome. The function of many cell surface receptors (such as glycosoaminoglycans, glycoproteins, proteins) which interact with viral capsid proteins or envelope glycoproteins has recently been elucidated. The list of cellular receptors (Table I) is still far from being final. The capsid components, similarly as the envelope glycoproteins, may form specific pocket like sites, which interact with the cell surface receptors. Neutralizing antibodies usually react with antigenic domains adjacent to the receptor binding site(s) and hamper the close contact inevitable for virion attachment. In the case of more complex viruses, such as herpes simplex virus, different viral glycoproteins interact with several cellular receptors. At progressed phase of adsorption the virions are engulfed into endocytic vesicles and the virion fusion domain(s) become(s) activated. The outer capsid components of reoviruses which participate in adsorption and fusion may get activated already in the lumen of digestive tract, i.e. before their engulfement by resorptive epithelium cells. Activation of the hydrophobic fusion domain(s) is a further important step allowing to pass through the lipid bilayer when penetrating the cell membrane in order to reach the cytosol. Activation of the virion fusion domain is accomplished by a conformation change, which occurs at acid pH (influenza virus hemagglutinin, s1 protein of the reovirus particle) and/or after protease treatment. The herpes simplex virus fusion factors (gD and gH) undergo conformation changes by a pH-independent mechanism triggered due to interaction with the cell surface receptor(s) and mediated by mutual interactions with the viral envelope glycoproteins. The virion capsid or envelope components participating in the entry and membrane fusion are not the only tools of virulence. The correct function of virus coded proteins, which participate in replication of the viral genome, and/or in the supply of necessary nucleotides, may be very essential. In the case of enteroviruses, which RNA ineracts with ribosomes directly, the correct configuration of the non-coding viral RNA sequence is crucial for initiation of translation occurring in the absence of the classical “cap” structure.
Murphy, B. R., Hinshaw, V. S., Sly, D. L.: Virulence of avian influenza A viruses for squirrel monkeys. Infect Immun 37, 1119-1126 (1982).
'Virulence of avian influenza A viruses for squirrel monkeys. ' () 37 Infect Immun : 1119 -1126.
Stott, E. J., Killington, R. A.: Rhinoviruses. Ann Rev Microbiol 26, 503-524 (1972).
'Rhinoviruses. ' () 26 Ann Rev Microbiol : 503 -524.
Melnick, L. J.: Enteroviruses: Polioviruses, Coxsackieviruses, Echoviruses and newer Enteroviruses. In: Fields, B. N., Knipe, D. M., Howley, P. M. (eds): Fields Virology, 3rd ed., Lipincott, Raven, 1996, pp. 655-712.
Fields Virology , () 655 -712.
Craighead, J. E.: Enteroviruses. In: Pathology and pathogenesis of human viral disease, Academic Press, San Diego, 2000, pp. 1-28.
Pathology and pathogenesis of human viral disease , () 1 -28.
Bodian, D.: Poliomyelitis. In: Rivers, T. M., Horsfall, F. L. (eds): Viral and Rickettsial Infections of Man, 3rd ed., J. B. Lippincott, Philadelphia, 1959, pp. 430-473.
Viral and Rickettsial Infections of Man , () 430 -473.
Rueckert, R. R.: Picornaviridae: the viruses and their replication. In: Fields, B. N., Knipe, D. M., Howley, P. M. (eds): Fields Virology, 3rd ed., Lipincott, Raven, 1996, pp. 609-654.
Fields Virology , () 609 -654.
McGoldrick, A., Macadam, A. J., Dunn, G., Rowe, A., Burlison, J., Minor, P. D., Meredith, J., Evans, D. D. J., Almond, J. W.: Role of mutations G-480 and C-6203 in the attenuation phenotype of Sabin poliovirus. J Virol 69, 7601-7605 (1995).
'Role of mutations G-480 and C-6203 in the attenuation phenotype of Sabin poliovirus. ' () 69 J Virol : 7601 -7605.
Rezapkin, G. V., Norwood, L. P., Taffs, R. E., Dragunsky, E. M., Levenbook, I. S., Chumakov, K. M.: Microevolution of type 3 Sabin strain of poliovirus un cell cultures and its implications for oral poliovirus vaccine quality control. Virology 211, 377-378 (1994).
'Microevolution of type 3 Sabin strain of poliovirus un cell cultures and its implications for oral poliovirus vaccine quality control. ' () 211 Virology : 377 -378.
Le, S. Y., Zucker, M.: Common structures of the 5'-non-coding RNA in enteroviruses and rhinoviruses: thermodynamical stability and statistical significance. J Mol Biol 216, 729-741 (1990).
'Common structures of the 5'-non-coding RNA in enteroviruses and rhinoviruses: thermodynamical stability and statistical significance. ' () 216 J Mol Biol : 729 -741.
Friedrich, F.: Genomic modifications in Sabin vaccine strains isolated from vaccination-associated cases, healthy contacts and healthy vaccinees. Acta Virol 40, 157-170 (1996).
'Genomic modifications in Sabin vaccine strains isolated from vaccination-associated cases, healthy contacts and healthy vaccinees. ' () 40 Acta Virol : 157 -170.
Friedrich, F.: Neurologic complications associated with oral poliovirus vaccine and genomic variability of the vaccine strains after multiplication in humans. Acta Virol 42, 187-195 (1998).
'Neurologic complications associated with oral poliovirus vaccine and genomic variability of the vaccine strains after multiplication in humans. ' () 42 Acta Virol : 187 -195.
Hogle, J. M., Chow, M., Filman, D.: Three dimensional structure of poliovirus at 2.9 A resolution. Science 229, 1358-1365 (1985).
'Three dimensional structure of poliovirus at 2.9 A resolution. ' () 229 Science : 1358 -1365.
Colonno, R. J.: Cell surface receptors for picornaviruses. BioEssays 5, 270-274 (1986).
'Cell surface receptors for picornaviruses. ' () 5 BioEssays : 270 -274.
Huber, A. A.: VCAM-1 is a receptor for encephalomyocarditis virus on murine vascular endothelial cells. J Virol 68, 3453-3458 (1994).
'VCAM-1 is a receptor for encephalomyocarditis virus on murine vascular endothelial cells. ' () 68 J Virol : 3453 -3458.
Horie, H., Koike, S., Kurata, T., Sato-Yoshida, T., Ise, I., Ota, Y., Abe, S., Hioki, K., Kato, H., Taya, C., Nomura, T., Hashizume, S., Yonekawa, H., Nomoto, A.: Transgenic mice carrying the human poliovirus receptor: new animal model for study of poliovirus neurovirulence. J Virol 68, 681-688 (1994).
'Transgenic mice carrying the human poliovirus receptor: new animal model for study of poliovirus neurovirulence. ' () 68 J Virol : 681 -688.
Tsiang, H.: An in vitro study of rabies pathogenesis. Bull Inst Pasteur 83, 41-56 (1985).
'An in vitro study of rabies pathogenesis. ' () 83 Bull Inst Pasteur : 41 -56.
Krumenacher, C., Baribaud, I., Kwan, L., Spear, P., Eisenberg, R., Cohen, G.: Effects of glycoprotein D binding and HSV infection on HveC/nectin 1 activity as a cell adhesion molecule. 2.02, 26th International Herpesvirus Workshop, 2001).
Bergelson, J. M., Shepley, M. P., Chan, B. M. C.: Identification of the integrin VLA-2 as a receptor for Echovirus. Science 255, 1718-1720 (1992).
'Identification of the integrin VLA-2 as a receptor for Echovirus. ' () 255 Science : 1718 -1720.
Mendelsohn, C., Wimmer, E., Racaniello, V.: Cellular receptor for poliovirus: molecular cloning, nucleotide sequence and expression of a new member of the immunoglobulin super-family. Cell 56, 855-865 (1989).
'Cellular receptor for poliovirus: molecular cloning, nucleotide sequence and expression of a new member of the immunoglobulin super-family. ' () 56 Cell : 855 -865.
Badger, J., Minor, I., Dremer, M. J., Oliveira, M. A., Smith, T. J., Griffith, J. P.: Structural analysis of a series of antiviral agents complexed with human rhinovirus 14. Proc Natn Acad Sci USA 85, 3304-3308 (1988).
'Structural analysis of a series of antiviral agents complexed with human rhinovirus 14. ' () 85 Proc Natn Acad Sci USA : 3304 -3308.
Fox, G., Parry, N. R., Barnett, P. V., McGinn, B., Rowlands, D. J., Brown, F.: The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RDG (arginine-glycine-aspartic acid). J Gen Virol 70, 625-637 (1989).
'The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RDG (arginine-glycine-aspartic acid). ' () 70 J Gen Virol : 625 -637.
Madshus, I. H., Olsnes, S., Sandwig, K.: Mechanism of entry into the cytosol of polivirus type 1: requirement of low pH. J Cell Biol 98, 1194-1200 (1984).
'Mechanism of entry into the cytosol of polivirus type 1: requirement of low pH. ' () 98 J Cell Biol : 1194 -1200.
Krug, R. M., Alonso-Caplen, F. V., Julkunen, I., Katz, M. G.: Expression and replication of the influenza virus genome. In: Krug, R. M. (ed.): The influenza viruses, Plenum Press, New York, 1989, pp. 89-152.
The influenza viruses , () 89 -152.
Lamb, R. A., Krug, R. M.: Orthomyxoviridae: the viruses and their replication. In: Fields, B. N., Knipe, D, M., Howley, P. M. (eds): Fields Virology, 3rd ed., Lipincott, Raven, 1996, pp. 1353-1395.
Fields Virology , () 1353 -1395.
Li, M. L., Ramirez, B. C., Krug, R. M.: RNA-dependent activation of primer RNA production by influenza virus polymerase: different regions of the same protein subunit constitute the required RNA binding sites. EMBO J 17, 5844-5852 (1998).
'RNA-dependent activation of primer RNA production by influenza virus polymerase: different regions of the same protein subunit constitute the required RNA binding sites. ' () 17 EMBO J : 5844 -5852.
Krug, R. M.: Priming of influenza viral RNA transcription by capped heterologous RNAs. Curr Top Microbiol Immunol 93, 125-149 (1981).
'Priming of influenza viral RNA transcription by capped heterologous RNAs. ' () 93 Curr Top Microbiol Immunol : 125 -149.
Plotch, S. J., Bouloy, M., Ulmanen, I., Krug, R. M.: A unique cap (m7GpppNXm)-dependent endonuclease cleaves capped RNAs to generate the primers that induce viral RNA transcription. Cell 23, 847-858 (1981).
'A unique cap (m7GpppNXm)-dependent endonuclease cleaves capped RNAs to generate the primers that induce viral RNA transcription. ' () 23 Cell : 847 -858.
Beaton, A. R., Krug, R. M.: Transcription antitermination during influenza virus template RNA synthesis requires nucleocapsid protein and the absence of a 5'-capped end. Proc Natn Acad Sci USA 113, 165-197 (1977).
'Transcription antitermination during influenza virus template RNA synthesis requires nucleocapsid protein and the absence of a 5'-capped end. ' () 113 Proc Natn Acad Sci USA : 165 -197.
Shapiro, G. I., Krug, R. M.: Influenza virus RNA replication in vitro: synthesis of viral template RNAs amd virion RNAs in the absence of an added primer. J Virol 62, 2285-2290 (1988).
'Influenza virus RNA replication in vitro: synthesis of viral template RNAs amd virion RNAs in the absence of an added primer. ' () 62 J Virol : 2285 -2290.
Chen, Z., Li, Y., Krug, R. M.: Inluenza virus protein targets poly(A)-binding protein II of the cellular 3'-end processing machinery. EMBO J 18, 2273-2283 (1999).
'Inluenza virus protein targets poly(A)-binding protein II of the cellular 3'-end processing machinery. ' () 18 EMBO J : 2273 -2283.
Verhoeyen, M., Fang, R., Min Jou, W., Devos, R., Huylebroeck, D., Saman, E., Fiers, W.: Antigenic drift between the hemagglutinin of the Hong-Kong influenza strains A/Aichi/2/68 and A/Vicoria/3/75. Nature 286, 771-776 (1980).
'Antigenic drift between the hemagglutinin of the Hong-Kong influenza strains A/Aichi/2/68 and A/Vicoria/3/75. ' () 286 Nature : 771 -776.
Lamb, R. A., Chopin, P. W.: The gene structure and replication of influenza virus. Ann Rev Biochem 52, 467-506 (1983).
'The gene structure and replication of influenza virus. ' () 52 Ann Rev Biochem : 467 -506.
Nobusawa, E., Aoyama, T., Kato, H., Suzuki, Y., Tateno, Y., Nakajima, K.: Comparison of complete amino acid sequences and receptor binding properties among 13 serotypes of hemagglutinin of influenza A viruses. Virology 182, 475-485 (1991).
'Comparison of complete amino acid sequences and receptor binding properties among 13 serotypes of hemagglutinin of influenza A viruses. ' () 182 Virology : 475 -485.
Wilson, I. A., Skehel, J. J., Wiley, D. C.: Structure of the hemagglutinin membrane glycoprotein of influenza virus at a 3 A resolution. Nature 289, 366-373 (1981).
'Structure of the hemagglutinin membrane glycoprotein of influenza virus at a 3 A resolution. ' () 289 Nature : 366 -373.
Doms, R. W., Lamb, R. A., Rose, J. K., Helenius, A.: Folding and assembly of viral membrane proteins. Virology 193, 545-562 (1993).
'Folding and assembly of viral membrane proteins. ' () 193 Virology : 545 -562.
Garten, W., Bosch, F. X., Linder, D., Rott, R., Klenk, H. D.: Proteolytic activation of the influenza virus hemagglutinin: the structure of the cleavage site and the enzymes involved in cleavage. Adv Exp Med Biol 142, 119-131 (1981).
'Proteolytic activation of the influenza virus hemagglutinin: the structure of the cleavage site and the enzymes involved in cleavage. ' () 142 Adv Exp Med Biol : 119 -131.
Ogasawa, T., Botoh, B., Suzuki, H., Asaka, J., Shimokata, K., Rott, R., Nagaui, Y.: Expression of factor X and its significance for the determination of paramyxovirus tropism in the chick embryo. EMBO J 11, 467-472 (1992).
'Expression of factor X and its significance for the determination of paramyxovirus tropism in the chick embryo. ' () 11 EMBO J : 467 -472.
Klenk, H. D., Garten, W.: Host cell proteases controlling virus pathogenicity. Trends in Microbiol 2, 39-43 (1994).
'Host cell proteases controlling virus pathogenicity. ' () 2 Trends in Microbiol : 39 -43.
Murphy, B. R., Webster, R. G.: Orthomyxoviruses. In: Fields, B. N., Knipe, D, M. (eds): Fields Virology, 2nd ed., Raven Press Ltd., New York, 1990, pp. 1091-1152.
Fields Virology , () 1091 -1152.
Wharton, S. A., Martin, S. R., Ruigrok, R. W. H., Kehel, J. J., Wiley, D. C.: Membrane fusion by peptide analogues of influenza virus hemagglutinin. J Gen Virol 69, 1847-1857 (1988).
'Membrane fusion by peptide analogues of influenza virus hemagglutinin. ' () 69 J Gen Virol : 1847 -1857.
Rogers, G. N., Paulson, J. C., Daniels, R. S., Skehel, J. J., Wilson, I. A., Wiley, D. C.: Single amino acid substitution in influenza hemagglutinin change receptor binding specificity. Nature 304, 76-78 (1983).
'Single amino acid substitution in influenza hemagglutinin change receptor binding specificity. ' () 304 Nature : 76 -78.
Scholtissek, C., Rohde, W., Harms, E., Rott, R.: Assignments of gene functions influenza A2-Singapore to genetic relatedness to other influenza strains. In.: Barry, R. D., Mahy, B. W. J. (eds): Negative strand viruses and the host cell, Academic Press, London, 1978, pp. 19-25.
Negative strand viruses and the host cell , () 19 -25.
Fang, R., Min Jou, W., Huylebroeck, D., Devos, R., Fiers, W.: Complex structure of A/Duck/Ukraine/63 influenza hemagglutinatin gene: animal virus progenitor of human H3 Hong Kong 1968 influenza hemagglutinin. Cell 25, 237-307 (1979).
'Complex structure of A/Duck/Ukraine/63 influenza hemagglutinatin gene: animal virus progenitor of human H3 Hong Kong 1968 influenza hemagglutinin. ' () 25 Cell : 237 -307.
Murphy, B. R., Webster, R. G.: Orthomyxoviruses. In: Fields, B. N., Knipe, D. M., Howley, P. M. (eds): Fields Virology, 3rd ed., Lipincott, Raven, 1996, pp. 1397-1445.
Fields Virology , () 1397 -1445.
Skehel, J. J., Bayley, P. M., Brown, E. B.: Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc Natn Acad Sci USA 53, 968-972 (1982).
'Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. ' () 53 Proc Natn Acad Sci USA : 968 -972.
Stegman, T., Booy, F. P., Witschut, J.: Effects of low pH on influenza virus: activation and inactivation of the membrane fusion capacity of the hemagglutinin. J Biol Chem 262, 17744-17749 (1987).
'Effects of low pH on influenza virus: activation and inactivation of the membrane fusion capacity of the hemagglutinin. ' () 262 J Biol Chem : 17744 -17749.
Wilson, I. A., Skehel, J. J., Wiley, D. C.: Structure of the hemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature 289, 366-373 (1981).
'Structure of the hemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. ' () 289 Nature : 366 -373.
Bullough, P. A., Hughson, F. M., Skehel, J. J., Wiley, D. C.: Structure of infleunza hemagglutinin at the pH of membrane fusion. Nature 371, 37-43 (1994).
'Structure of infleunza hemagglutinin at the pH of membrane fusion. ' () 371 Nature : 37 -43.
Wiley, D. C., Skehel, J. J.: The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Ann Rev Biochem 56, 365-394 (1987).
'The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. ' () 56 Ann Rev Biochem : 365 -394.
Weis, W., Brown, I. M., Cusack, S.: Structure of the influenza virus haemagglutinin complexed with its receptor sialic acid. Nature 333, 426-431 (1988).
'Structure of the influenza virus haemagglutinin complexed with its receptor sialic acid. ' () 333 Nature : 426 -431.
Sugrue, R. J., Hay, A. J.: Structural characteristics of the M2 protein of influenza A viruses: evidence that it forms a tetrameric channel. Virology 179, 617-624 (1991).
'Structural characteristics of the M2 protein of influenza A viruses: evidence that it forms a tetrameric channel. ' () 179 Virology : 617 -624.
Oxford, J. S., Galbraith, A.: Antiviral activity of amantadine: a review of laboratory and clinical data. Pharmacol Ther 11, 181-262 (1980).
'Antiviral activity of amantadine: a review of laboratory and clinical data. ' () 11 Pharmacol Ther : 181 -262.
Hay, A. J.: The action of amantanamines against influenza viruses: inhibition of the M2 ion channel protein. Semin Virol 3, 21-30 (1992).
'The action of amantanamines against influenza viruses: inhibition of the M2 ion channel protein. ' () 3 Semin Virol : 21 -30.
Dietschold, B., Rupprecht, Ch. E., Zhen Fang, Fu., Koprowski, H.: Rhabdoviruses. In: Fields, B. N., Knipe, D. M., Howley, P. M. (eds): Fields Virology, 3rd ed., Lipincott, Raven, 1996, pp. 1137-1159.
Fields Virology , () 1137 -1159.
Anilionis, A., Wunner, W. H., Curtis, P.: Structure of the glycoprotein gene of rabies virus. Nature (London) 294, 275-278 (1985).
'Structure of the glycoprotein gene of rabies virus. ' () 294 Nature (London) : 275 -278.
Harrison, A. K., Murphy, F. A.: Lyssavirus infection of muscle spindles and motor end plates in striated muscle of hamsters. J Arch Virol 57, 167 (1978).
'Lyssavirus infection of muscle spindles and motor end plates in striated muscle of hamsters. ' () 57 J Arch Virol : 167.
Watson, H. D., Tignor, G. H., Smith, A. L.: Entry of rabies virus into the peripheral nerves of mice. J Gen Virol 56, 371-382 (1981).
'Entry of rabies virus into the peripheral nerves of mice. ' () 56 J Gen Virol : 371 -382.
Lentz, T. L., Burrage, T. G., Smith, A. L., Crick, J., Tignor, G.: Is the acetylcholine receptor a rabies virus receptor? Science 215, 182-184 (1982).
'Is the acetylcholine receptor a rabies virus receptor? ' () 215 Science : 182 -184.
Burrage, T. G., Tignor, G. H., Smith, A. L.: Rabies virus binding at neuromuscular junctions. Virus Res 2, 273-289 (1985).
'Rabies virus binding at neuromuscular junctions. ' () 2 Virus Res : 273 -289.
Lentz, T. L., Benson, R. J. J., Klimovicz, D., Wilson, P. T., Hawrot, E.: Binding of rabies virus to purified Torpedo acetylcholine receptor. Mol Brain Res 1, 211-219 (1986).
'Binding of rabies virus to purified Torpedo acetylcholine receptor. ' () 1 Mol Brain Res : 211 -219.
Dietschold, B., Wiktor, T. J., Trojanovski, J. Q.: Differences in cell to cell spread of pathogenic and apathogenic rabies virus strains in vivo and in vitro. J Virol 56, 12-18 (1985).
'Differences in cell to cell spread of pathogenic and apathogenic rabies virus strains in vivo and in vitro. ' () 56 J Virol : 12 -18.
Coulon, P., Rollin, P. E., Flamand, A.: Molecular basis of rabies virus virulence. II. Identification of a site on the CVS glycoprotein associated with virulence. J Gen Virol 64, 693-696 (1983).
'Molecular basis of rabies virus virulence. II. Identification of a site on the CVS glycoprotein associated with virulence. ' () 64 J Gen Virol : 693 -696.
Whitt, M. A., Zagouras, P., Crise, B., Rose, J. K.: A fusion defective mutant of the vesicular stomatitis virus glycoprotein. J Virol 64, 4907-4913 (1990).
'A fusion defective mutant of the vesicular stomatitis virus glycoprotein. ' () 64 J Virol : 4907 -4913.
Morimoto, K. Ni, Y. J., Kawai, A.: Syncytium formation is induced in the murine neuroblastoma cell cultures which produce pathogenic type G proteins of the rabies virus. Virology 189, 203-216 (1992).
'Syncytium formation is induced in the murine neuroblastoma cell cultures which produce pathogenic type G proteins of the rabies virus. ' () 189 Virology : 203 -216.
Tsiang, H.: Evidence for an intraaxonal transport of fixed and street rabies virus. J Neuropathol Exp Neurol 38, 286-292 (1978).
'Evidence for an intraaxonal transport of fixed and street rabies virus. ' () 38 J Neuropathol Exp Neurol : 286 -292.
Nibert, M. L., Schiff, L. A., Fields, B. N.: Reoviruses and their replication. In: Fields, B. N., Knipe, D. M., Howley, P. M. (eds): Fields Virology, 3rd ed., Lipincott, Raven, 1996, pp. 1557-1596.
Fields Virology , () 1557 -1596.
Weiner, H. L., Drayna, D., Averill, D. R.: Molecular basis of reovirus virulence: role of S1 gene. Proc Natn Acad Sci USA 74, 5744-5748 (1977).
'Molecular basis of reovirus virulence: role of S1 gene. ' () 74 Proc Natn Acad Sci USA : 5744 -5748.
Lee, P. W. K., Hayes, E. C., Joklik, W. K.: Protein σ1 is the reovirus cell attachment protein. Virology 108, 156-163 (1981).
'Protein σ1 is the reovirus cell attachment protein. ' () 108 Virology : 156 -163.
Masri, S. A., Nagata, L., Mah, D. C., Lee, P. W.: Functional expression in E. coli of cloned reovirus σ1 gene encoding the viral cell attachment target protein σ1. Virology 149, 83-90 (1986).
'Functional expression in E. coli of cloned reovirus σ1 gene encoding the viral cell attachment target protein σ1. ' () 149 Virology : 83 -90.
Gentsch, J., Pacitti, A.: Differential interaction of reovirus type 3 with sialylated components on animal cells. Virology 161, 245-248 (1987).
'Differential interaction of reovirus type 3 with sialylated components on animal cells. ' () 161 Virology : 245 -248.
Paul, R. W., Choi, A. H., Lee, P. W. K.: The alpha-anomeric form of sialic acid is the minimal receptor determinant recognized by reovirus. Virology 172, 382-385 (1989).
'The alpha-anomeric form of sialic acid is the minimal receptor determinant recognized by reovirus. ' () 172 Virology : 382 -385.
Tang, D., Strong, J. E., Lee, P. W. K.: Recognition of the epidermal growth factor receptor by reovirus. Virology 197, 412-414 (1993).
'Recognition of the epidermal growth factor receptor by reovirus. ' () 197 Virology : 412 -414.
Choi, A. H. C., Lee, P. W. K.: Does the beta-adrenergic receptor function as a reovirus receptor? Virology 163, 191-197 (1988).
'Does the beta-adrenergic receptor function as a reovirus receptor? ' () 163 Virology : 191 -197.
Choi, A. H. C., Paul, R. W., Lee, P. W. K.: Reovirus binds to multiple plasma membrane proteins of mouse L fibroblasts. Virology 178, 316-320 (1990).
'Reovirus binds to multiple plasma membrane proteins of mouse L fibroblasts. ' () 178 Virology : 316 -320.
Sauve, G. J., Saragovi, H. U., Greene, M. I.: Reovirus receptors. Adv Virus Res 42, 232-341 (1992).
'Reovirus receptors. ' () 42 Adv Virus Res : 232 -341.
Dermody, T. S., Nibert, M. L., Bassel-Duby, R., Fields, B. N.: A S1 region important for hemagglutination by serotype 3 reovirus strains. J Virol 64, 5173-5176 (1990).
'A S1 region important for hemagglutination by serotype 3 reovirus strains. ' () 64 J Virol : 5173 -5176.
Huismans, H., Joklik, W. K.: Reovirus coded polypeptides in infected cells: isolation of two native monomeric polypeptides with high affinity for single stranded and double stranded RNA, respectively. Virology 70, 411-424 (1976).
'Reovirus coded polypeptides in infected cells: isolation of two native monomeric polypeptides with high affinity for single stranded and double stranded RNA, respectively. ' () 70 Virology : 411 -424.
Lemioux, R., Lemay, G., Millward, S.: The viral protein σ3 participates in translation of late viral messanger RNA in reovirus infected cells. J Virol 61, 2472-2479 (1987).
'The viral protein σ3 participates in translation of late viral messanger RNA in reovirus infected cells. ' () 61 J Virol : 2472 -2479.
Schiff, L. A., Nibert, M. L., Co, M. S., Brown, E. G., Fields, B. N.: Distinct binding sites for zinc and double stranded RNA in the reovirus outer capsid protein σ3. Mol Cell Biol 8, 273-282 (1984).
'Distinct binding sites for zinc and double stranded RNA in the reovirus outer capsid protein σ3. ' () 8 Mol Cell Biol : 273 -282.
Bodkin, D. K., Nibert, M. L., Fields, B. N.: Proteolytic digestion of reovirus in the intestinal lumens of neonatal mice. J Virol 63, 4676-4681 (1989).
'Proteolytic digestion of reovirus in the intestinal lumens of neonatal mice. ' () 63 J Virol : 4676 -4681.
Bass, D. M., Bodkin, D., Dambrauskas, R., Trier, J. S., Fields, B. N., Wolf, J. L.: Intraluminal proteolytic activation plays an importany role in replication of type 1 reovirus in the intestines of neonatal mice. J Virol 64, 1830-1833 (1990).
'Intraluminal proteolytic activation plays an importany role in replication of type 1 reovirus in the intestines of neonatal mice. ' () 64 J Virol : 1830 -1833.
Tillotson, L., Shatkin, A. J.: Reovirus polypeptide σ3 and N-terminal myristoylation of polypeptide μ1/μ1C is required for site specific cleavage to μ1C in transfected cells. J Virol 66, 2180-2186 (1992).
'Reovirus polypeptide σ3 and N-terminal myristoylation of polypeptide μ1/μ1C is required for site specific cleavage to μ1C in transfected cells. ' () 66 J Virol : 2180 -2186.
Nibert, M. L., Fields, B. N.: A carboxy terminal fragment of protein μ1/μ1C is present in infectious subvirion particles of mammalian reoviruses and is proposed to have a role in penetration. J Virol 66, 6408-6418 (1992).
'A carboxy terminal fragment of protein μ1/μ1C is present in infectious subvirion particles of mammalian reoviruses and is proposed to have a role in penetration. ' () 66 J Virol : 6408 -6418.
Sturzenbecker, L. J., Nibert, M., Furlong, D., Fields, B. N.: Intracellular digestion of reovirus particles requires a low pH and is an essential step in the viral infectious cycle. J Virol 61, 2351-2361 (1987).
'Intracellular digestion of reovirus particles requires a low pH and is an essential step in the viral infectious cycle. ' () 61 J Virol : 2351 -2361.
Armstrong, G. D., Paul, R. W., Lee, P. W.: Studies on reovirus receptors of L-cells: virus binding characteristics and comparison with reovirus receptors of erythrocytes. Virology 138, 37-48.
'Studies on reovirus receptors of L-cells: virus binding characteristics and comparison with reovirus receptors of erythrocytes. ' () 138 Virology : 37 -48.
Estes, M. K.: Rotaviruses and their replication. In: Fields, B. N., Knipe, D. M., Howley, P. M. (eds): Fields Virology 3rded., Lipincott, Raven, 1996, pp. 1625-1655.
Fields Virology , () 1625 -1655.
Tyler, K. L., Fields, B. N.: Reoviruses. In: Fields, B. N., Knipe, D. M., Howley, P. M. (eds): Fields Virology, 3rd ed., Lipincott, Raven, 1996, pp. 1597-1623.
Fields Virology , () 1597 -1623.
Tyler, K. L., Fields, B. N.: Pathogenesis of viral infections. In: Fields, B. N., Knipe, D. M., Howley, P. M. (eds): Fields Virology, 3rd ed., Lipincott, Raven, 1996, pp. 173-217.
Fields Virology , () 173 -217.
Whitley, R. J.: Herpes simplex viruses. In: Fields, B. N., Knipe, D. M., Howley, P. M. (eds): Fields Virology, 3rd ed., Lipincott, Raven, 1996, pp. 2297-2342.
Fields Virology , () 2297 -2342.
Roizman, B., Sears, A. E.: Herpes simplex viruses and their replication. In: Fields, B. N., Knipe, D. M., Howley, P. M. (eds): Fields Virology, 3rd ed., Lipincott, Raven, 1996, pp. 2231-2295.
Fields Virology , () 2231 -2295.
Rajčon;áni, J., Ďurmanová, V.: Early expression of herpes simplex virus proteins and reactivation of latent infection. Folia Microbiol 45, 7-28 (2000).
'Early expression of herpes simplex virus proteins and reactivation of latent infection. ' () 45 Folia Microbiol : 7 -28.
Rajčon;áni, J., Vojvodová, A: The role of herpes simplex virus glycoproteins in the virus replication cycle. Acta Virol. 42, 103-118 (1998).
'The role of herpes simplex virus glycoproteins in the virus replication cycle. ' () 42 Acta Virol. : 103 -118.
Lingen, M., Seck, T., Dehoust, U., Weise, K., Falke, D.: Amino acid substitutions in gD mediate the ability of "fusion from without" - positive herpes simplex type 1 strains to penetrate at 4 °C in the presence of soluble glycoprotein D. Intervirology 38, 283-289 (1994).
'Amino acid substitutions in gD mediate the ability of "fusion from without" - positive herpes simplex type 1 strains to penetrate at 4 °C in the presence of soluble glycoprotein D. ' () 38 Intervirology : 283 -289.
Dingwell, K. S., Brunetti, C. R., Hendricks, R. L., Tang, Q., Tang, M., Rainbow, A. J., Johnson, D. C.: Herpes simplex virus glycoprotein E and I facilitate cell to cell spread in vivo and across junctions of cultured cells. J Virol 68, 834-845 (1994).
'Herpes simplex virus glycoprotein E and I facilitate cell to cell spread in vivo and across junctions of cultured cells. ' () 68 J Virol : 834 -845.
Rajčon;áni, J., Herget, U., Kaerner, H. C.: Spread of herpes simplex virus (HSV) strains SC16, ANG, ANGpath and its gC minus and gE minus mutants in DBA-2 mice. Acta Virol 305-320 (1990).
Rajčon;áni, J., Kúdelová, M.: Glycoprotein K of herpes simplex virus: a transmembrane protein encoded by the UL53 gene which regulates membrane fusion. Virus Genes 18, 81-90 (1998).
'Glycoprotein K of herpes simplex virus: a transmembrane protein encoded by the UL53 gene which regulates membrane fusion. ' () 18 Virus Genes : 81 -90.
Gage, P. J., Levine, M., Glorioso, J. C.: Syncytium-inducing mutations localize to two discrete regions within the cytoplasmic domain of herpes simplex virus type 1 glycoprotein B. J Virol 67, 2191-2201 (1993).
'Syncytium-inducing mutations localize to two discrete regions within the cytoplasmic domain of herpes simplex virus type 1 glycoprotein B. ' () 67 J Virol : 2191 -2201.
Rajčon;áni, J., Küdelová, M., Oravcová, I., Vojvodová, A., Košovsdký, J., Matis, J.: Characterization of strain HSZP of herpes simplex virus type 1. Folia Microbiol 44, 713-719 (1999).
'Characterization of strain HSZP of herpes simplex virus type 1. ' () 44 Folia Microbiol : 713 -719.
Küdelová, M., Vojvodová, A., Rajčon;áni, J.: Syn strains HSZP and ANGpath of herpes simplex virus type 1 do not contain mutations in the regions of UL53 gene relevant to syncytium formation. Acta Virol 42, 41-45 (1998).
'Syn strains HSZP and ANGpath of herpes simplex virus type 1 do not contain mutations in the regions of UL53 gene relevant to syncytium formation. ' () 42 Acta Virol : 41 -45.
Košovský, J., Vojvodová, A., Oravcová, I., Kúdelová, M., Matis, J., Rajčon;áni, J.: Herpes simplex virus strain HSZP glycoprotein B gene: comparison of mutations among strains differing in virulence. Virus Genes 20, 25-31 (2000).
'Herpes simplex virus strain HSZP glycoprotein B gene: comparison of mutations among strains differing in virulence. ' () 20 Virus Genes : 25 -31.
Košt'ál, M., Bačon;ík, I., Rajčon;áni, J., Kaerner, H.: Replacement of glycoprotein B gene in the herpes simplex type 1 strain ANGpath DNA by that originating from nonpathogenic strain KOS reduces the pathogenicity of recombinant virus. Acta Virol 38, 77-88 (1994).
'Replacement of glycoprotein B gene in the herpes simplex type 1 strain ANGpath DNA by that originating from nonpathogenic strain KOS reduces the pathogenicity of recombinant virus. ' () 38 Acta Virol : 77 -88.
Kumel, G., Schroder, C. H., Kaerner, H. C.: Neurovirulence and latency in inbred mice: two HSV-1 intrastrain variants of different pathogenicity. Med Microbiol Immunol 174, 313-324 (1986).
'Neurovirulence and latency in inbred mice: two HSV-1 intrastrain variants of different pathogenicity. ' () 174 Med Microbiol Immunol : 313 -324.
Yeager, C. L., Ashman, R. A., Wiliams, R. K.: Human aminopeptidase N is a receptor for coronavirus 229E. Nature 357, 420-422 (1992).
'Human aminopeptidase N is a receptor for coronavirus 229E. ' () 357 Nature : 420 -422.
Nemerow, G. R., Wolfert, R., McNaughton, M. E.: Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2). J Virol 55, 345-351 (1985).
'Identification and characterization of the Epstein-Barr virus receptor on human B lymphocytes and its relationship to the C3d complement receptor (CR2). ' () 55 J Virol : 345 -351.
Fingeroth, J. D., Clabby, M. L., Strominger, J. D.: Characterization of a T-lymphocyte Epstein-Barr virus/C3d receptor (CD21). J Virol 62, 1442-1447 (1988).
'Characterization of a T-lymphocyte Epstein-Barr virus/C3d receptor (CD21). ' () 62 J Virol : 1442 -1447.
McClure, J. E.: Cellular receptor for Epstein-Barr virus. Progr Med Virol 39, 116-138 (1992).
'Cellular receptor for Epstein-Barr virus. ' () 39 Progr Med Virol : 116 -138.
Shich, M. T., Wudunn, D., Montgomery, R. I.: Cell surface receptors for herpes simplex virus are heparine sulphate proteoglycans. J Cell Biol 116, 1273-1281 (1992).
'Cell surface receptors for herpes simplex virus are heparine sulphate proteoglycans. ' () 116 J Cell Biol : 1273 -1281.
Spear, P. G.: Entry of alpha-herpesviruses into cells. Semin Virol 4, 167-180 (1993).
'Entry of alpha-herpesviruses into cells. ' () 4 Semin Virol : 167 -180.
Campadelli-Fiume, G., Cocchi, F., Menotti, L., Lopez, M.: The novel receptors that mediate entry of herpes simplex viruses into cells. Rev Med Virol 10, 395-319 (2000).
'The novel receptors that mediate entry of herpes simplex viruses into cells. ' () 10 Rev Med Virol : 395 -319.
Weise, K., Kaernaer, H. C., Glorioso, J., Schroder, C. H.: Replacement of glycoprotein B gene sequences in herpes simplex virus type 1 strain ANG by corresponding sequences of the strain KOS causes changes in plaque morphology and neuropathogenicity. J Gen Virol 68, 1909-1919 (1987).
'Replacement of glycoprotein B gene sequences in herpes simplex virus type 1 strain ANG by corresponding sequences of the strain KOS causes changes in plaque morphology and neuropathogenicity. ' () 68 J Gen Virol : 1909 -1919.
Rajčon;áni, J., Vojvodová, A., Matis, J., Kúdelová, M., Dragúňová, J., Krivjanská, M., Zelník, V.: The syn3 strain HSZP of herpes simplex virus type 1 is not pathogenic for mice and shows limited neural spread. Virus Res 43, 33-44 (1996).
'The syn3 strain HSZP of herpes simplex virus type 1 is not pathogenic for mice and shows limited neural spread. ' () 43 Virus Res : 33 -44.
Yuhasz, S., Stevens, G.: Glycoprotein B is a specific determinant of herpes simplex type 1 neuroinvasiveness. J Virol 67, 5948-5954 (1993).
'Glycoprotein B is a specific determinant of herpes simplex type 1 neuroinvasiveness. ' () 67 J Virol : 5948 -5954.
DeLuca, N. A., Bzik, D., Bond, V. C., Person, S., Snipes, W.: Nucleotide sequences of herpes simplex virus type 1 affecting virus entry, cell fusion and production of gB (VP7). Virology 122, 411-423 (1982).
'Nucleotide sequences of herpes simplex virus type 1 affecting virus entry, cell fusion and production of gB (VP7). ' () 122 Virology : 411 -423.
Sakharkiz-Langroody, A., Holland, T.: Identification of fusion-from-without determinants of herpes simplex virus glycoprotein B. Virology 227, 153-159 (1997).
'Identification of fusion-from-without determinants of herpes simplex virus glycoprotein B. ' () 227 Virology : 153 -159.
Oravcová, I., Kúdelová, M., Mlčon;uchová, J., Matis, J., Bystrická, M., Westra, D. F., Wellin-Wester, G. W., Rajčon;áni, J.: Characterization of glycoprotein C from the strain HSZP of herpes simplex 1. Acta Virol 44, 99-108 (2000).
'Characterization of glycoprotein C from the strain HSZP of herpes simplex 1. ' () 44 Acta Virol : 99 -108.
Rosen, A., Ernst, F., Koch, H. G., Gederblom, H., Darai, G., Hadar, J., Tabor, E., Ben-Hur, T., Becker, Y.: Replacement of the deletion in the genome (0.762-0.789) of virulent HSV-1 HFEM using cloned MluI DNA fragment (0.7615-0.796) of virulent HSV-1 F leads to generation of virulent intratype recombinant. Virus Res 5, 157-175 (1986).
'Replacement of the deletion in the genome (0.762-0.789) of virulent HSV-1 HFEM using cloned MluI DNA fragment (0.7615-0.796) of virulent HSV-1 F leads to generation of virulent intratype recombinant. ' () 5 Virus Res : 157 -175.
Chou, J., Roizman, B.: The γ34.5 gene of herpes simplex virus function which blocks the host response to infection maps in the homologous domain of the genes expressed during growth arrest and DNA damage. Proc Natn Acad Sci USA 91, 5247-5251 (1994).
'The γ34.5 gene of herpes simplex virus function which blocks the host response to infection maps in the homologous domain of the genes expressed during growth arrest and DNA damage. ' () 91 Proc Natn Acad Sci USA : 5247 -5251.
Wickham, T. J., Mathias, P., Cheresh, D. A., Nemerow, G. W.: Integrins avβ3 and avβ5 promote adenovirus internalization but not virus attachment. Cell 73, 309-319 (1993).
'Integrins avβ3 and avβ5 promote adenovirus internalization but not virus attachment. ' () 73 Cell : 309 -319.
Yokomori, K., Lai, M. C.: Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. J Virol 66, 6194-6199 (1992).
'Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. ' () 66 J Virol : 6194 -6199.
Dveskler, G. S., Dieffenbach, C. W., Cardellichio, C. B.: Several members of the carcinoembryonic antigen-related glycoprotein family are functional receptors for the coronavirus mouse hepatitis virus A59. J Virol 67, 1-7 (1993).
'Several members of the carcinoembryonic antigen-related glycoprotein family are functional receptors for the coronavirus mouse hepatitis virus A59. ' () 67 J Virol : 1 -7.
Grundy, J. E., McKeating, J. A., Griffits, P. D.: Cytomegalovirus strain AD169 binds beta-2 microglobulin in vitro after release from cells. J Gen Virol 68, 777-784 (1987).
'Cytomegalovirus strain AD169 binds beta-2 microglobulin in vitro after release from cells. ' () 68 J Gen Virol : 777 -784.
Compton, T., Nowlin, D. M., Cooper, N. R.: Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate. Virology 193, 834-841 (1993).
'Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate. ' () 193 Virology : 834 -841.
Wykes, M. N., Shellam, G. R., McCluskey, J.: Murine cytomegalovirus interacts with major histocompatibility complex I molecules to establish cellular infection. J Virol 67, 4182-4189 (1993).
'Murine cytomegalovirus interacts with major histocompatibility complex I molecules to establish cellular infection. ' () 67 J Virol : 4182 -4189.
Higa, H. H., Rogers, G. N., Paulson, J. C.: Influenza virus hemagglutinins differentiate between receptor determinants bearing N-acetyl-N-glycollyl- and N-O-diacetylmuraminic acid groups. Virology 144, 279-282 (1985).
'Influenza virus hemagglutinins differentiate between receptor determinants bearing N-acetyl-N-glycollyl- and N-O-diacetylmuraminic acid groups. ' () 144 Virology : 279 -282.
Weiss, R. A.: Human immunodeficiency virus receptors. Semin Virol 3, 426-431 (1992).
'Human immunodeficiency virus receptors. ' () 3 Semin Virol : 426 -431.
Greve, J. M., Davies, G., Meyer, A. M.: The major rhinovirus receptor is ICAM-1. Cell 56, 839-847 (1989).
'The major rhinovirus receptor is ICAM-1. ' () 56 Cell : 839 -847.
Staunton, D. E., Merluzzi, V. J., Rothlein, R.: A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell 56, 849-853 (1989).
'A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. ' () 56 Cell : 849 -853.
Bergelson, J. M., St. John, N., Kawaguchi, S.: Infection by Echoviruses 1 and 8 depends on the alpha-2 subunit of human VLA-2. J Virol 67, 6847-6852 (1993).
'Infection by Echoviruses 1 and 8 depends on the alpha-2 subunit of human VLA-2. ' () 67 J Virol : 6847 -6852.
Epstein, D. A., Marsh, Y. V., Schreiber, A. B.: Epidermal growth factor receptor occupancy inhibits vaccinia virus infection. Nature 318, 663-665 (1985).
'Epidermal growth factor receptor occupancy inhibits vaccinia virus infection. ' () 318 Nature : 663 -665.
Dalgleish, A. G., Beverly, P. C. L., Clapham, P. R.: The CD4 antigen is an essential component of the receptor for the AIDS retrovirus. Nature 312, 763-767 (1985).
'The CD4 antigen is an essential component of the receptor for the AIDS retrovirus. ' () 312 Nature : 763 -767.
Klatzman, D., Champagne, E., Charamaret, S.: T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature 312, 767-768 (1984).
'T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. ' () 312 Nature : 767 -768.
Sattentau, Q. J., Weiss, R. A.: The CD4 antigen: physiologic ligand and HIV receptor. Cell 52, 631-633 (1988).
'The CD4 antigen: physiologic ligand and HIV receptor. ' () 52 Cell : 631 -633.
Weiss, R. A.: Human immunodeficiency virus receptors. Semin Virol 3, 79-84 (1992).
'Human immunodeficiency virus receptors. ' () 3 Semin Virol : 79 -84.
Bhat, S., Spitalnik, S. L., Gonzalez-Scarano, F.: Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120. Proc Natn Acad Sci USA 88, 7131-7134 (1991).
'Galactosyl ceramide or a derivative is an essential component of the neural receptor for human immunodeficiency virus type 1 envelope glycoprotein gp120. ' () 88 Proc Natn Acad Sci USA : 7131 -7134.
Lentz, T.: Rabies virus receptors. Trends Neurosci 8, 360-364 (1985).
'Rabies virus receptors. ' () 8 Trends Neurosci : 360 -364.
Hahnham, C. A., Zhao, F., Tignor, G. H.: Evidence from the anti-idiotype network that the acetylcholine receptor is a rabies virus receptor. J Virol 67, 530-542 (1993).
'Evidence from the anti-idiotype network that the acetylcholine receptor is a rabies virus receptor. ' () 67 J Virol : 530 -542.
Superti, F., Hauttecocoeur, B., Morelec, M. J.: Involvement of gangliosides in rabies virus infection. J Gen Virol 67, 47-56 (1986).
'Involvement of gangliosides in rabies virus infection. ' () 67 J Gen Virol : 47 -56.
Schlegel, R., Tralka, S., Willingham, M. C.: Inhibition of VSV binding and infectivity of phosphatidylserine. Is phosphatidylserine a VSV binding site? Cell 32, 639-646 (1983).
'Inhibition of VSV binding and infectivity of phosphatidylserine. Is phosphatidylserine a VSV binding site? ' () 32 Cell : 639 -646.
Wang, K. S., Kuhn, R. J., Strauss, E. G.: High affinity laminin receptor is a receptor for Sindbis virus in mammalian cells. J Virol 66, 4992-5001 (1992).
'High affinity laminin receptor is a receptor for Sindbis virus in mammalian cells. ' () 66 J Virol : 4992 -5001.
Helenius, A., Morein, B., Fries, E.: Human HLA-A and HLA-B and murine H2K and H2D histocompatibility antigens are cell surface receptors for Semliki Forest virus. Proc Natn Acad Sci USA 75, 3846-3850 (1978).
'Human HLA-A and HLA-B and murine H2K and H2D histocompatibility antigens are cell surface receptors for Semliki Forest virus. ' () 75 Proc Natn Acad Sci USA : 3846 -3850.
Rajčon;áni, J., Kaerner, H. C.: Kaerner, H. C.: Regions US6 and US7 of herpes simplex virus type 1 DNA encoding glycoproteins D and 1 may influence neuroinvasivity. Acta Virol 38, 89-95 (1994).
'Kaerner, H. C.: Regions US6 and US7 of herpes simplex virus type 1 DNA encoding glycoproteins D and 1 may influence neuroinvasivity. ' () 38 Acta Virol : 89 -95.
Sears, A. E., Halliburton, I. W., Meignier, B., Silver, S., Roizman, B.: Herpes simplex virus 1 mutant deleted in the α22 gene: growth and gene expression in permissive and restrictive cells and establishment of latency in mice. J Virol 55, 338-346 (1985).
'Herpes simplex virus 1 mutant deleted in the α22 gene: growth and gene expression in permissive and restrictive cells and establishment of latency in mice. ' () 55 J Virol : 338 -346.
Brandt, C. R., Kintner, R. L., Pumfrey, A. M., Visally, R. J., Grau, D. R.: The herpes simplex virus ribonucleotide reductase is required for ocular virulence. J Gen Virol 72, 2043-2049 (1991).
'The herpes simplex virus ribonucleotide reductase is required for ocular virulence. ' () 72 J Gen Virol : 2043 -2049.
Rajčon;áni, J.: DNA regions and genes determining virulence of herpes simplex virus. Acta Virol 36, 208-222 (1992).
'DNA regions and genes determining virulence of herpes simplex virus. ' () 36 Acta Virol : 208 -222.
Preston, C. M.: Repression of viral transcription during herpes simplex virus latency. J Gen Virol 81, 1-19 (2000).
'Repression of viral transcription during herpes simplex virus latency. ' () 81 J Gen Virol : 1 -19.
Lloyd, R. M., Shatkin, A. J.: Translational stimulation by reovirus polypeptide σ3: substitution for VA1-RNA and inhibition of phosphorylation of the a-subunit of eukaryotic initiation factor-II. J Virol 66, 6878-6884 (1992).
'Translational stimulation by reovirus polypeptide σ3: substitution for VA1-RNA and inhibition of phosphorylation of the a-subunit of eukaryotic initiation factor-II. ' () 66 J Virol : 6878 -6884.
Dryden, K. A., Wang, G., Yeager, M., Nibert, M. L., Coombs, K. M., Furlong, D. B., Field, B. N., Baker, T. S.: Early steps in reovirus infection are associated with dramatic changes in supramiolecular structure and protein conformation: analysis of virions and subviral particles by cryoelectron microscopy and image reconstruction. J Cell Biol 122, 1023-1041, (1993).
'Early steps in reovirus infection are associated with dramatic changes in supramiolecular structure and protein conformation: analysis of virions and subviral particles by cryoelectron microscopy and image reconstruction. ' () 122 J Cell Biol : 1023 -1041.
Cameron, J. M., McDougall, I., Marsden, H. S., Preston, V. G., Ryan, D. M., Subak-Sharpe, J. H.: Ribonucleotide reductase encoded by herpes simplex virus is a determinant of the pathogenicity of the virus in mice and a valid antiviral target. J Gen Virol 69, 2607-2612 (1988).
'Ribonucleotide reductase encoded by herpes simplex virus is a determinant of the pathogenicity of the virus in mice and a valid antiviral target. ' () 69 J Gen Virol : 2607 -2612.
Jacobson, J. G., Leib, D A., Doldstein, D. I., Bogard, C. C., Schaffer, Pam., Weller, S. K., Coen, D. M.: A herpes simplex virus ribonucleotide reductase deletion mutant is defective for productive, acute and reactivable infections of mice and for replication in mouse cells. Virology 3, 276-283 (1989).
'A herpes simplex virus ribonucleotide reductase deletion mutant is defective for productive, acute and reactivable infections of mice and for replication in mouse cells. ' () 3 Virology : 276 -283.
Whitley, R. J., Kern, E., Chattopadhy, S., Chou, J., Roizman, B.: Replication establishment of latency, and induced reactivation of herpes simplex virus γ34.5 deletion mutants in rodent models. J Clin Invest 91, 2837-2843 (1993).
'Replication establishment of latency, and induced reactivation of herpes simplex virus γ34.5 deletion mutants in rodent models. ' () 91 J Clin Invest : 2837 -2843.